Menu

Image of the Day: Zip It

The cytoskeleton of endothelial cells and adhesion proteins work together to help build new blood vessels.  

Sep 7, 2018
Sukanya Charuchandra

ABOVE: Vascular system of a two-day-old zebrafish embryo (magenta: endothelial cells, light blue: blood cells)
UNIVERSITY OF BASEL, BIOZENTRUM

Endothelial cells, which line the inside of blood vessels, extend out of existing vessels to form new capillaries. During this process in zebrafish, these cells remain glued to each other, preventing hemorrhage, according to a study published August 31 in Nature Communications.

Using high-resolution time-lapse imaging, researchers peered into transparent zebrafish embryos undergoing vascularization. As the cytoskeleton within an endothelial cell helped it elongate and move ahead, an adhesion protein helped stick it to the next cell, while another protein strengthened the new joint. “This repetitive process enables the cell to slowly creep forward,” says coauthor Heinz-Georg Belting of the University of Basel, Switzerland, in a statement

I. Paatero et al., “Junction-based lamellipodia drive endothelial cell rearrangements in vivo via a VE-cadherin-F-actin based oscillatory cell-cell interaction,” Nat Commun, doi:10.1038/s41467-018-05851-9, 2018.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.